External Device for Erectile Dysfunction (3D-Erect)
Launched by STANFORD UNIVERSITY · Nov 9, 2020
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called 3D-Erect, is investigating a new non-invasive device designed to help men with erectile dysfunction (ED) achieve successful and satisfying sexual intercourse. The device is 3D-printed and aims to provide a safe and effective option for men struggling with ED, which can stem from various causes, including medical treatments for prostate cancer or emotional issues.
Men aged 18 and older who are experiencing moderate to severe erectile dysfunction may be eligible to participate, especially if they have a female partner who is also willing to join the study. Participants can expect to use the external device during sexual intercourse and provide feedback on its effectiveness. It's important to note that those who are not willing to try sexual intercourse or cannot use the device for any reason will not be eligible for the trial. Overall, this study aims to explore a new way to help men regain their sexual function and improve their quality of life.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • males \>18 years old suffering from any cause moderate to severe erectile dysfunction (e.g. ED after radical prostatectomy and/or radiation therapy for prostate cancer and or other pelvic malignancies affecting the sexual potency; emotional and psychological ED; organic vascular and/or metabolic ED etc.)
- • having a female partner willing to participate in the study.
- Exclusion Criteria:
- • not willing to attempt sexual vaginal intercourse with their partner
- • inability to wear/operate the external penile device for any reason
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stanford, California, United States
Patients applied
Trial Officials
Michael Eisenberg, MD
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials